Proadrenomedullin for prediction of early and mid-term mortality in patients hospitalized for community-acquired pneumonia
Amongst patients admitted for CAP, the use of proADM obtained in the ED may be useful for identifying patients at greatest risk of mortality, with a similar predictive capacity to the CURB65 score.
Authors
- Amaia Artaraz (ORCID: https://orcid.org/0000-0002-1869-9193)
- Urko Aguirre (ORCID: https://orcid.org/0000-0002-8049-3030)
- Aitor Ballaz
- Javier Aspa (ORCID: https://orcid.org/0000-0002-1283-995X)
- Pedro Pablo España (ORCID: https://orcid.org/0000-0001-5723-8253)
- Ana Jódar
- Rosario Menéndez (ORCID: https://orcid.org/0000-0002-3592-3839)
- José María Quintana (ORCID: https://orcid.org/0000-0003-2170-7876)
- Ane Uranga (ORCID: https://orcid.org/0000-0003-1816-9835)
- Carmen Mar
- Salvador Bello
Institutions
- Hospital Universitari i Politècnic La Fe (ES)
- Hospital Universitario Miguel Servet (ES)
- Hospital de Galdakao (ES)
- Hospital Universitario de La Princesa (ES)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2025-09-08
- DOI
- https://doi.org/10.1515/cclm-2025-0481
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00